ArticleScientific reports2025
Rapid reagent free COVID19 detection using MEMS based FTIR spectroscopy and machine learning in NIR and MIR regions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optical Biosensors-Principles of Operation and Applications.Micromachines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents rapid, reagent-free detection of COVID-19 using miniaturized MEMS-based Fourier-transform infrared (FTIR) spectrometers integrated with machine learning models. Two portable spectrometers analyze 363 nasopharyngeal swab samples stored in viral transport medium (VTM). The first spectrometer covers the near-infrared (NIR) region (1.3-2.6 μm) and second spectrometer extends from the near infrared to the mid infrared (MIR) region (1.75-4.0 μm). The NIR system uses a transmission configuration, while the one extended to the MIR performs attenuated total reflectance (ATR) measurements on both wet and dried samples. Spectral data undergo preprocessing and analysis using interval partial least squares discriminant analysis (iPLS-DA), with model training and evaluation conducted through Monte Carlo cross-validation. The MIR wet sample model achieves a diagnostic performance with 79% accuracy, a 98% sensitivity, and an area under the curve (AUC) of 0.8. The MIR dry sample model achieves an 80% accuracy and an AUC of 0.79, while the NIR model reaches 66% accuracy and an AUC of 0.64. Spectral features appear in the Amide A and B regions in the MIR range, and in the C-H overtone bands in the NIR range. The full measurement process, including sample handling, completes in under six minutes, supporting its suitability for real-time, point-of-care (POC) testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.